DS
RXST icon

David Shaw’s RxSight RXST Stock Holding History

David Shaw’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-5,400
Closed -$267K – 4805
2024
Q3 		$267K Sell
5,400
-2,300
-30% -$118K ﹤0.01% 4032
2024
Q2 		$463K Buy
+7,700
New +$440K ﹤0.01% 3665

Other funds holding RXST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

David Shaw's RXST Position: Q2 2026 in Review

David Shaw increased its RxSight (RXST) stake by 1.3% in Q2 2026, buying an estimated $154K and bringing the position to 1,985,215 shares worth $9.57M. The position accounts for ﹤0.01% of the portfolio, ranked #1848.

David Shaw first reported a position in RXST in Q2 2023 and has held it in 13 quarters since. The position peaked at $19.6M in Q4 2025. 150 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • David Shaw held 1,985,215 shares of RxSight worth $9.57M as of Q2 2026.
  • David Shaw bought 25,483 RxSight shares in Q2 2026, an estimated $154K.
  • RxSight made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #1848 holding.
  • David Shaw first reported a position in RxSight in Q2 2023 and has held it in 13 quarters since.
  • David Shaw's RxSight position peaked at $19.6M in Q4 2025.
  • 150 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.